SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues related to Biomedical Advanced Research and Development Authority (BARDA)" funding;and issues related to HR1892 "Bipartisan Budget Act of 2018.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JUAN MACHADO | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
| ELIZABETH STOWER | — |
Copyright/Patent/Trademark CPT
Issues with march-in rights within H.R 2810 National Defense Authorization Act for Fiscal Year 2018.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
Medicare/Medicaid MMM
Issues related to the repeal and non-interference in Part D.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JUAN MACHADO | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
| ELIZABETH STOWER | — |
Economics/Economic Development ECN
Issues related to site expansions.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
Health Issues HCR
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related to Pandemic and All Hazards Preparedness (PAHPA)reauthorization; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to Right to Try; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to FDA User Fee Reauthorization; issues related to HR2212 "CREATES Act of 2017"; and issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017".
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JUAN MACHADO | — |
| KATIE OPPENHEIM | — |
| AMY L REDL | — |
| ELIZABETH STOWER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.